Web stats for Eliquis - eliquis.co.uk
1.67 Rating by ClearWebStats
eliquis.co.uk is 1 decade 3 years 3 months old. This website has a #1,221,853 rank in global traffic. It has a .co.uk as an domain extension. This domain is estimated value of $ 480.00 and has a daily earning of $ 2.00. While no active threats were reported recently by users, eliquis.co.uk is SAFE to browse.
Traffic Report of Eliquis
| Daily Unique Visitors: | 394 |
| Daily Pageviews: | 788 |
Estimated Valuation
| Income Per Day: | $ 2.00 |
| Estimated Worth: | $ 480.00 |
Search Engine Indexes
| Google Indexed Pages: | Not Applicable |
| Yahoo Indexed Pages: | Not Applicable |
| Bing Indexed Pages: | Not Applicable |
Search Engine Backlinks
| Google Backlinks: | Not Applicable |
| Bing Backlinks: | Not Applicable |
| Alexa BackLinks: | Not Applicable |
Safety Information
| Google Safe Browsing: | No Risk Issues |
| Siteadvisor Rating: | Not Applicable |
| WOT Trustworthiness: | Not Applicable |
| WOT Privacy: | Not Applicable |
| WOT Child Safety: | Not Applicable |
Website Ranks & Scores
| Google Pagerank: | Not Applicable |
| Alexa Rank: | 1,221,853 |
| Domain Authority: | Not Applicable |
Google Pagerank
PR 0 out of 10
PageSpeed Score
67
Siteadvisor Rating
Not Applicable
Where is eliquis.co.uk server located?
Hosted IP Address:
198.155.184.133
Hosted Country:
US
Location Latitude:
37.751Location Longitude:
-97.822Social Engagement
| Facebook Shares: | Not Applicable |
| Facebook Likes: | Not Applicable |
| Facebook Comments: | Not Applicable |
| Twitter Count (Tweets): | Not Applicable |
| Linkedin Shares: | Not Applicable |
| Delicious Shares: | Not Applicable |
Page Resources Breakdown
Homepage Links Analysis
Website Inpage Analysis
| H1 Headings: | 11 | H2 Headings: | Not Applicable |
| H3 Headings: | Not Applicable | H4 Headings: | Not Applicable |
| H5 Headings: | Not Applicable | H6 Headings: | Not Applicable |
| Total IFRAMEs: | Not Applicable | Total Images: | 14 |
| Google Adsense: | Not Applicable | Google Analytics: | Not Applicable |
Websites Hosted on Same IP (i.e. 198.155.184.133)
Krebs.de â Vorsorge, Diagnose & Therapie von Krebs | Von Bristol-Myers Squibb
Hier finden Sie umfassende Informationen zu Krebserkrankungen, die Ihnen und Ihrer Familie eine erste Orientierungshilfe sein sollen. Jetzt zur Ãbersicht.
1,515,845 
$ 480.00
OPDIVO® (nivolimab) | Relapsed or Progressed cHL after auto-HSCT
OPDIVO® (nivolumab), for the treatment of patients with classical Hodgkin Lymphoma (cHL) that has relapsed or progressed after autologous HSCT and brentuximab vedotin or after 3 or more lines of systemic therapy that includes autologous HSCT.
Not Applicable $ 8.95
OPDIVO® (nivolumab) | Patient Gateway
OPDIVO® (nivolumab) is a prescription medication. Read about its indications, side effects, and more.
642,380 $ 1,200.00
SUSTIVA® (efavirenz)
Learn about SUSTIVA® (efavirenz) a prescription medication. Read Indications and Important Safety Information.
Not Applicable $ 8.95
HIV Treatment for HIV-1 Infection | REYATAZ® (atazanavir)
Official website for REYATAZ® (atazanavir) an HIV treatment medicine. Get information about how REYATAZ treats HIV-1 once daily with other HIV medications.
Not Applicable $ 8.95
HTTP Header Analysis
Http-Version: 1.1
Status-Code: 200
Status: 200 OK
Date: Tue, 14 Mar 2017 00:17:05 GMT
X-XSS-Protection: 1; mode=block
Cache-Control: public, max-age=600,s-maxage=0
Content-Security-Policy: referrer origin-when-cross-origin
X-Powered-By: Salesforce.com ApexPages
P3P: CP="CUR OTR STA"
Content-Language: en-US
Expires: Tue, 14 Mar 2017 00:27:06 GMT
Last-Modified: Tue, 14 Mar 2017 00:17:06 GMT
X-FRAME-OPTIONS: SAMEORIGIN
Content-Type: text/html;charset=UTF-8
Vary: Accept-Encoding
Content-Encoding: gzip
Connection: close
Status-Code: 200
Status: 200 OK
Date: Tue, 14 Mar 2017 00:17:05 GMT
X-XSS-Protection: 1; mode=block
Cache-Control: public, max-age=600,s-maxage=0
Content-Security-Policy: referrer origin-when-cross-origin
X-Powered-By: Salesforce.com ApexPages
P3P: CP="CUR OTR STA"
Content-Language: en-US
Expires: Tue, 14 Mar 2017 00:27:06 GMT
Last-Modified: Tue, 14 Mar 2017 00:17:06 GMT
X-FRAME-OPTIONS: SAMEORIGIN
Content-Type: text/html;charset=UTF-8
Vary: Accept-Encoding
Content-Encoding: gzip
Connection: close
Domain Information for eliquis.co.uk
| Domain Registrar: |
Nominet UK
|
|---|---|
| Registration Date: | 2011-01-24 1 decade 3 years 3 months ago |
| Last Modified: | 2017-01-20 7 years 3 months 3 days ago |
Domain Nameserver Information
| Host | IP Address | Country | |
|---|---|---|---|
| ns1.bms.com |
|
198.155.167.250 |
United States
|
| ns2.bms.com |
|
198.155.167.248 |
United States
|
| ns3.bms.com |
|
198.155.223.8 |
United States
|
DNS Record Analysis
| Host | Type | TTL | Extra |
|---|---|---|---|
| eliquis.co.uk | A | 86400 |
IP:198.155.184.133 |
| eliquis.co.uk | NS | 86400 |
Target:ns1.bms.com |
| eliquis.co.uk | NS | 86400 |
Target:ns2.bms.com |
| eliquis.co.uk | NS | 86400 |
Target:ns4.bms.com |
| eliquis.co.uk | NS | 86400 |
Target:ns3.bms.com |
| eliquis.co.uk | SOA | 86400 |
MNAME:ns1.bms.com RNAME:dnsadmin.bms.com Serial:2011091410 Refresh:10800 Retry:3600 Expire:604800 |
Similarly Ranked Websites to Eliquis
Turismo en El Salvador
Somo las mejor guía turistica de El Salvador con información de hoteles, pueblos, playas, lagos, museos, sitios turísticos y más.
1,221,855 $ 480.00
Scuola e Tecnologia - Costruire la scuola del futuro
Tante realtà eccellenti e insegnanti preparati hanno già saputo coniugare scuola e tecnologia per metterle al servizio del proprio lavoro ma ancora molto si deve fare.
1,221,855 $ 480.00
Italiano Tube8 video porno senza registrazione
Scopri free porn italiano e tube 8 video porno completamente gratuito e ogni giorno. Offriamo il più grande archivio italiano porno.
1,221,857 $ 480.00
Full WHOIS Lookup for eliquis.co.uk
Domain name:
eliquis.co.uk
Registrant:
Bristol-Myers Squibb Company
Registrant type:
Unknown
Registrant's address:
PO Box 5400
Princeton
NJ
08543-5400
United States
Data validation:
Nominet was able to match the registrant's name and address against a 3rd party data source on 10-Dec-2012
Registrar:
Corporation Service Company (UK) Limited [Tag = CSC-CORP-DOMAINS]
URL: http://www.cscprotectsbrands.com
Relevant dates:
Registered on: 24-Jan-2011
Expiry date: 24-Jan-2018
Last updated: 20-Jan-2017
Registration status:
Registered until expiry date.
Name servers:
ns1.bms.com
ns2.bms.com
ns3.bms.com
WHOIS lookup made at 00:17:12 14-Mar-2017
--
This WHOIS information is provided for free by Nominet UK the central registry
for .uk domain names. This information and the .uk WHOIS are:
Copyright Nominet UK 1996 - 2017.
You may not access the .uk WHOIS or use any data from it except as permitted
by the terms of use available in full at http://www.nominet.uk/whoisterms,
which includes restrictions on: (A) use of the data for advertising, or its
repackaging, recompilation, redistribution or reuse (B) obscuring, removing
or hiding any or all of this notice and (C) exceeding query rate or volume
limits. The data is provided on an 'as-is' basis and may lag behind the
register. Access may be withdrawn or restricted at any time.
eliquis.co.uk
Registrant:
Bristol-Myers Squibb Company
Registrant type:
Unknown
Registrant's address:
PO Box 5400
Princeton
NJ
08543-5400
United States
Data validation:
Nominet was able to match the registrant's name and address against a 3rd party data source on 10-Dec-2012
Registrar:
Corporation Service Company (UK) Limited [Tag = CSC-CORP-DOMAINS]
URL: http://www.cscprotectsbrands.com
Relevant dates:
Registered on: 24-Jan-2011
Expiry date: 24-Jan-2018
Last updated: 20-Jan-2017
Registration status:
Registered until expiry date.
Name servers:
ns1.bms.com
ns2.bms.com
ns3.bms.com
WHOIS lookup made at 00:17:12 14-Mar-2017
--
This WHOIS information is provided for free by Nominet UK the central registry
for .uk domain names. This information and the .uk WHOIS are:
Copyright Nominet UK 1996 - 2017.
You may not access the .uk WHOIS or use any data from it except as permitted
by the terms of use available in full at http://www.nominet.uk/whoisterms,
which includes restrictions on: (A) use of the data for advertising, or its
repackaging, recompilation, redistribution or reuse (B) obscuring, removing
or hiding any or all of this notice and (C) exceeding query rate or volume
limits. The data is provided on an 'as-is' basis and may lag behind the
register. Access may be withdrawn or restricted at any time.